Personalized neurostimulation for children with gastrointestinal disorders
Official title: Autonomic Reactivity to Restore a Dysregulated Brain-Gut Axis Via Targeted Therapy
Run by Medical College of Wisconsin · NCT06863207 · Data updated 2026-11-12
This study is testing a new treatment that combines personalized nerve stimulation and hypnotherapy to see if it can help children with stomach problems feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Medical College of Wisconsin Academic / other |
| Locations | 1 site (Milwaukee, Wisconsin) |
| Status | Recruiting |
| Started | January 24, 2025 |
| Main results expected | December 2028 |
| Study ends | June 2029 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT06863207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking children aged 11 to 18 who meet diagnostic criteria for cyclic vomiting syndrome or functional dyspepsia and exhibit symptoms of autonomic dysfunction.
✕Probably not a fit
Patients with organic diseases explaining their symptoms, severe mental health disorders, or those requiring parenteral nutrition are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of personalized percutaneous electrical nerve field stimulation (PENFS) combined with hypnotherapy to treat children suffering from functional gastrointestinal disorders (FGIDs) and autonomic nervous system dysregulation. The researchers aim to assess real-time autonomic nervous system (ANS) regulation using a novel software while personalizing stimulation parameters based on individual sensory thresholds. The study will evaluate the feasibility and efficacy of these interventions over a six-week period, focusing on improvements in symptoms and autonomic function. By understanding the underlying mechanisms of gut-brain interaction, the study seeks to provide targeted treatment options for affected children.
Why it matters
Potential benefit: If successful, this approach could lead to more effective, personalized treatments for children with debilitating gastrointestinal disorders and associated autonomic dysfunction.
How similar studies have gone: While the approach of combining neurostimulation with hypnotherapy is innovative, similar studies have shown promise in treating related conditions, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 11 to 18 years of age * English speaking * meeting Rome IV diagnostic criteria for cyclic vomiting syndrome or functional dyspepsia and willingness to participate and consent/assent to the study * All subjects will have a constellation of chronic symptoms indicative of autonomic dysfunction for minimum 3 months: postural dizziness/lightheadedness, syncope, palpitations, fatigue, sleep disturbance, thermoregulatory abnormalities and cognitive impairment with upright position +/- abnormal autonomic testing if performed per standard of care as per American Autonomic Society consensus criteria. Exclusion Criteria: * Presence of organic disease that may explain symptoms * Requirement for parenteral nutrition * Developmental delays precluding accurate symptom report * Severe dermatological condition or active infection of external or middle ear * Implanted electrical device * Severe mental health disorder not controlled by therapy (schizophrenia, bipolar disease, severe depression, post-traumatic distress disorder) and/or psychotic features which could influence symptom report or ANS measurements and result in adverse reactions to hypnosis therapy
Where it's running
-
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Katja Karrento, MD — Medical College of Wisconsin
- Study coordinator: Elaina Schueler, BS
- Email: eschueler@mcw.edu
- Phone: 4142663695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guided imagery therapy app for kids with functional abdominal pain
This study tests a guided imagery therapy app to see if it helps school-age children with functional abdominal pain disorders.
-
How different FODMAP diets affect people with IBS and functional dyspepsia
This test will try low FODMAP, gentle FODMAP, and standard dietary advice in adults with IBS or functional dyspepsia to see how they change symptoms, gut bacteria, gut barrier function, and quality of life.
-
Low-FODMAP Diet vs Standard Dietary Advice for Functional Dyspepsia
This study tests whether a low-FODMAP diet helps adults with functional dyspepsia compared with standard dietary advice.
-
Pain Reprocessing Therapy for Functional Dyspepsia
A small pilot test to see if a psychological therapy that uses exposure techniques can lessen digestive symptoms and help daily functioning in people with functional dyspepsia.
-
Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa
This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.
-
Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers
Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.